Why the study?
Despite advances in pulmonary arterial hypertension therapy improving outcomes, poor survival remains a reality worldwide, including Korea.
Early detection through proactive screening and intensive, individualized PAH therapy using deep phenotyping are crucial for improving the prognosis of PAH patients in Korea.
Authors
No takes yet. Share an insight, caveat, or question.
Late diagnosis and low combination therapy rates persist in Korean PAH; leaves open optimal screening and upfront strategies for Asian registries.
Jang et al. (2019) studied this question.